[OA057] Comparative dose planning for Ru-106 brachytherapy and proton therapy for choroidal melanomas

Eye-preservation using brachytherapy (BT) and proton therapy (PT) are commonly used as primary treatments for uveal melanomas (UM). Choice of modality generally depends on local availability rather than direct assessment of the two techniques. We conducted a comparative dose planning study, estimating biologically effective doses (BED) to the tumour, macula and optic nerve head (ONH).
Source: Physica Medica: European Journal of Medical Physics - Category: General Medicine Authors: Source Type: research